In lung cancer treatment, gene sequencing has been performed mainly as a companion diagnostic approach for identifying mutations in genes such as EGFR and anaplastic lymphoma kinase (ALK) and subsequent selection of molecular target drugs [8,9,10]. Here, ALK is linked to lung cancer.